-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Public Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSBlog
Venues used for promotional speaker programs are evolving as they reopen: IQVIA data reveals how
May 25, 2021
IQVIA’s comprehensive, longitudinal survey series — the only one of its kind in the industry — has been yielding a rich trove of insights around how and when venues have been reopening and adapting to the new demands placed upon them by the COVID-19 pandemic. The newest tranche of data shows that venues are reopening and eager to resume hosting promotional programming and other face-to-face events.
At the end of the first quarter, fully two-thirds — 67% — of nearly 4,400 venues around the United States reported to IQVIA surveyors that they had reopened. A mere 5% reported that they were permanently closed, and an additional 6% characterized their status as temporarily closed.
Venues that are welcoming groups for venue-based programming have undertaken new sanitation protocols and invested in new hygiene equipment and staff training to mitigate coronavirus transmission. Six in 10 require masks or mask and glove usage for all parties, including staff, patrons and anyone else on-site. Nearly half — 47% — have masks and/or gloves on hand to offer attendees, and 33% require speakers and presenters to be masked.
Social distancing and sanitization are paramount: 67% of venues have sanitizer available in restrooms and at tables for attendee use, 44% require six feet of space between groups or dining table set-ups and 22% require between 30 and 60 minutes to sanitize spaces in between groups or reservations.
The likelihood that virtual and hybrid events will remain an indelible part of the promotional speaker programming matrix for the foreseeable future means that program managers and planners have to prioritize the technological capabilities that can facilitate the integration of face-to-face and remote learning and networking. Venues are adapting to these demands in the following ways.
More than six in 10 — 61% — of venues offer virtual capability, and 61% have audiovisual capability. In an acknowledgement of the specialized skills required to operate high-quality virtual and hybrid programs, 62% allow third-party audiovisual setup, although 38% require additional time to set and service the function room when a third-party audiovisual provider is in attendance.
The trend lines in the venue survey responses for all of the above metrics are ascendent: More venues in March than in January had audiovisual and virtual capabilities, and a growing number of venues provided accommodations for program directors to bring in their own audiovisual specialists — an indication that venues are responding quickly to the requirements today’s promotional speaker programs need to be successful.
In an encouraging sign for promotional speaker programs, a snapshot of those scheduled for the first half of 2021 confirm the recovery of in-person HCP engagements. More than four in 10 of the speaker programs scheduled as of June, are planned as in-person meetings.
While the high percentage of virtual programs still taking place indicates that the path back to full resumption of in-person events lies in the future, the trajectory on a month-to-month basis shows a clear trend towards a reversion to the norm of in-person events.
In January, just 18% of sales rep program scheduling requests were in-person, with the remainder virtual. But the quarter showed an increasing prevalence of in-person programs being requested by sales reps: 23% of those requested in February were in-person, and that number climbed to 28% in March.
Nearly two-thirds — 63% — of IQVIA’s clients had resumed venue-based programs, and 75% had resumed in-office programs. These steps are being taken with no small degree of deliberation, though, and life sciences companies are approaching the resumption of face-to-face promotional activities with great caution.
More than one in 10 — 12% — of IQVIA clients report that they are currently operating under internal corporate guidelines governing the percentage of in-person events they are permitted to conduct. This suggests that companies are adjusting their protocols as the guidance from public health regulators is refined in response to current COVID-19 rates and growing knowledge about the impact of activities such as in-person programs health conditions.
Such risk aversion is not only prudent, but imperative in a highly complex environment with little precedent for guidance and a panoply of approaches. State-by-state variations in venue reopening and recovery illustrate the tremendous challenge ahead for life sciences companies and their promotional communication strategies.
With no consensus from regulators, promotional speaker program managers have little guidance for navigating this fast-evolving situation. This is where IQVIA’s compliance-centric operational framework and unparalleled degree of industry visibility have proven to be a strategic combination on which life sciences companies can rely: IQVIA has the in-depth insight and granular knowledge base to guide program producers stymied by this complex and ever-shifting array of expectations and demands.
IQVIA meeting and events experts support the ever-changing speaker programs environment. In addition to hands-on support, we deliver strategic insight and integrated solutions — with embedded compliance — to facilitate HCP engagements where, when and however they take place. To hear more insights about the current state of HCP Engagements, please register for our Connected Intelligence TechIQ Series.